Inicio › Cáncer de mama triple negativo › Nueva York

Ensayos clínicos de Cáncer de mama triple negativo en Nueva York

46 estudios sobre Cáncer de mama triple negativo buscan participantes en Nueva York.

Ciudades en Nueva York

Texto oficial del estudio (inglés)

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Columbia University Medical Center, New York
Memorial Sloan Kettering, New York

ReclutandoFase 1/2

Edades de 12 en adelante · Todos los sexos · Actualizado el 2 oct 2026 · NCT04585750

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

NYU Langone Medical Center - Perlmutter Cancer Center (NYU Cancer Institute), New York
NYU Langone Medical Center - Perlmutter Cancer Center (NYU Cancer Institute), New York
Icahn School of Medicine at Mount Sinai, New York
y 2 más

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 2 oct 2026 · NCT06465069

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

START New York Long Island LLC, Lake Success

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 2 oct 2026 · NCT06270706

Testing the Addition of Anti-Cancer Drug, ZEN003694 (ZEN-3694) and PD-1 Inhibitor (Pembrolizumab), to Standard Chemotherapy (Nab-Paclitaxel) Treatment in Patients With Advanced Triple-Negative Breast Cancer

NYU Langone Hospital - Long Island, Mineola
Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 30 sept 2026 · NCT05422794

First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, as Monotherapy and in Combination With Anticancer Therapy in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer

NYU Longone Health (Long Island), Long Island City
NYU Longone Health (Manhattan), Manhattan

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 29 sept 2026 · NCT06799065

Study of AVZO-021 in Patients With Advanced Solid Tumors

Avenzo Therapeutics Recruiting Site, Mineola
Avenzo Therapeutics Recruiting Site, New York

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 28 sept 2026 · NCT05867251

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

NYU Langone Medical Center, New York

ReclutandoEstudio observacional

Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT04981119

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

The Blavatnik Family- Chelsea Medical Center at Mount Sinai ( Site 0135), New York
Icahn School of Medicine at Mount Sinai ( Site 0123), New York
Memorial Sloan Kettering Cancer Center ( Site 0067), New York
y 1 más

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT06393374

A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)

Perlmutter Cancer Center at NYU Langone Hospital - Long Island ( Site 0073), Mineola
Laura and Isaac Perlmutter Cancer Center ( Site 0003), New York

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT06841354

Intratumoral N17350 in Advanced Solid Tumors

Roswell Park Comprehensive Cancer Center, Buffalo

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 23 sept 2026 · NCT07339176

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

Memorial Sloan Kettering Cancer Center Head Neck Services, New York

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 21 sept 2026 · NCT05983432

A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors

Icahn School of Medicine at Mt. Sinai, New York
Memorial Sloan Kettering Cancer Center, New York

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 17 sept 2026 · NCT07020117

A Study of Pembrolizumab and Ablation (Cryoablation or Histotripsy) in People With Breast Cancer

Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities ), Commack
Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
Memorial Sloan Kettering Cancer Center (All protocol activites), New York
y 1 más

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 14 sept 2026 · NCT06246968

First in Human Study of TUB-030 in Patients With Advanced Solid Tumors

Mount Sinai, New York

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 11 sept 2026 · NCT06657222

Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)

Hematology Oncology Associates of Central New York, PC, East Syracuse
Northwell Health, Lake Success
Laura and Isaac Perlmutter Cancer Canter, New York
y 5 más

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 9 sept 2026 · NCT05633654

Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer

NYP/Weill Cornell Medical Center, New York

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 9 sept 2026 · NCT03606967

A Study of SDX-7320 in Combination With Eribulin for People With Breast Cancer

Memorial Sloan Kettering Suffolk - Commack (All Protocol Activities), Commack
Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
y 1 más

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 9 sept 2026 · NCT05570253

A Study of Sofe-M in Participants With Selected Advanced Solid Tumors

NYU Langone Health - Long Island, Mineola
New York University (NYU) Clinical Cancer Center, New York
David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 4 sept 2026 · NCT06400472

Toci +/- SOC Chemo for Metastatic Triple Negative and ER-positive, HER2-negative Breast Cancers

Roswell Park Comprehensive Cancer Center, Buffalo

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 3 sept 2026 · NCT05846789

A Phase II Study of Biomarker-Guided De-escalation Using Anthracycline-Free Neoadjuvant Chemoimmunotherapy in Early-Stage Triple Negative Breast Cancer (TNBC) Patients With High Tumor-Infiltrating Lymphocytes (TILs)

SUNY Upstate Medical University, Syracuse

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 24 ago 2026 · NCT07743190

A Study of Cyclophosphamide, Methotrexate, Fluorouracil (CMF) for People With Breast Cancer

Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities), Commack
Memorial Sloan Kettering at Westchester (Limited Protocol Activities), Harrison
Memorial Sloan-Kettering Cancer Center (All Protocol Activities), New York
y 1 más

ReclutandoFase 2

Edades de 70 en adelante · Todos los sexos · Actualizado el 17 ago 2026 · NCT07768436

Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors

Memorial Sloan Kettering Cancer Center, New York

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 13 ago 2026 · NCT05985655

A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)

Memorial Sloan Kettering Cancer Center, New York
Local Institution - 1037, Syracuse
Clinical Research Alliance, Westbury
y 1 más

ReclutandoFase 2/3

Edades de 18 en adelante · Todos los sexos · Actualizado el 10 ago 2026 · NCT06926868

A Phase 1 of CTX-8371 in Patients With Advanced Malignancies

Roswell Park Cancer Institute, Buffalo

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 28 jul 2026 · NCT06150664

A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors

Memorial Sloan Kettering Cancer Center - Investigational Drug Service Pharmacy, Long Island City
Memorial Sloan Kettering Cancer Center - David H. Koch Center for Cancer Care (74th Street)., New York
Memorial Sloan Kettering Cancer Center 53rd street., New York
y 1 más

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 22 jul 2026 · NCT07318805

Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer

Roswell Park Cancer Institute, Buffalo

ReclutandoFase 2

Edades de 18 en adelante · Mujeres · Actualizado el 21 jul 2026 · NCT04348747

A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors

New York University Langone Health, New York
ICHAN School of Medicine at Mount Sinai, New York
Memorial Sloan Kettering Cancer Center, New York

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 29 jun 2026 · NCT05377996

A Study of LY4175408 in Participants With Advanced Cancer

Columbia University, New York
David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 23 jun 2026 · NCT07046923

Study of XB010 in Subjects With Solid Tumors

Montefiore Medical Center - Montefiore Medical Park, The Bronx

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 22 jun 2026 · NCT06545331

A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

START New York Long Island, LLC, Lake Success

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 18 jun 2026 · NCT07503808

BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia

New York Medicine-New York-Presbyterian Hospital, New York
Montefiore Medical Center - Montefiore Hospital, New York
Montefiore Medical Center, The Bronx

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 15 jun 2026 · NCT05768932

A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types

Memorial Sloan Kettering Cancer Center, New York

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 4 jun 2026 · NCT04300556

Neoadjuvant Dupilumab, Pembrolizumab, Paclitaxel, and Carboplatin in Locally Advanced Triple Negative Breast Cancer

Mount Sinai Health System, New York

ReclutandoFase 1 temprana

Edades de 18 en adelante · Todos los sexos · Actualizado el 14 may 2026 · NCT06637306

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

Roswell Park Cancer Institute, Buffalo
Laura and Isaac Perlmutter Cancer Center / NYU Langone Health, New York
Columbia University Medical Center, New York
y 2 más

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 6 may 2026 · NCT01042379

Tamoxifen and Pegylated Liposomal Doxorubicin for the Treatment of Patients With Metastatic or Inoperable, Locally Advanced Triple Negative Breast Cancer

Roswell Park Cancer Institute, Buffalo

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 24 abr 2026 · NCT06434064

A Study of Tetrathiomolybdate (TM) Plus Capecitabine

NYU Langone perimutter Cancer Center, New York

ReclutandoFase 1/2

Edades de 18 a 80 · Todos los sexos · Actualizado el 20 abr 2026 · NCT06134375

Access to Genetic Testing in Underserved Patients With Cancer

University of Rochester, Rochester

ReclutandoSe aceptan voluntarios sanos

Edades de 18 en adelante · Todos los sexos · Actualizado el 18 mar 2026 · NCT06422455

A Dose Randomization Study of Bulumtatug Fuvedotin in TNBC Patients Previously Treated With ADCs

Memorial Sloan Kettering Cancer Center, New York

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 17 mar 2026 · NCT06908928

Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease

Memorial Sloan Kettering Cancer Center @ Commack, Commack
Memorial Sloan Kettering Westchester, Harrison
Memorial Sloan Kettering Cancer Center, New York
y 1 más

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 27 feb 2026 · NCT03808337

A Study of Radiation Therapy With Pembrolizumab and Olaparib or Other Radiosensitizers in Women Who Have Triple-Negative or Hormone-Receptor Positive/Her2 Negative Breast Cancer

Memorial Sloan Kettering Commack (Limited Protocol Activities), Commack
Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
y 1 más

ReclutandoFase 2

Edades de 18 en adelante · Mujeres · Actualizado el 17 feb 2026 · NCT04683679

De ClinicalTrials.gov, datos obtenidos el 5 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.